NumerixS Investment Technologies’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

NumerixS Investment Technologies’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-600	Closed	-$20K	–	1020
2020 Q2	$20K	Sell	600 -4,400	-88%	-$140K	0.01%	952
2020 Q1	$136K	Buy	+5,000	New	+$139K	0.07%	342
2019 Q3	–	Sell	-400	Closed	-$5K	–	1340
2019 Q2	$5K	Buy	+400	New	+$5.31K	﹤0.01%	1007
2018 Q2	–	Sell	-300	Closed	-$5K	–	1433
2018 Q1	$5K	Buy	+300	New	+$5K	﹤0.01%	1008
2017 Q4	–	Sell	-2,000	Closed	-$37K	–	1441
2017 Q3	$37K	Sell	2,000 -5,300	-73%	-$88.6K	0.01%	980
2017 Q2	$123K	Sell	7,300 -10,100	-58%	-$154K	0.02%	785
2017 Q1	$232K	Buy	17,400 +6,100	+54%	+$95.5K	0.03%	674
2016 Q4	$170K	Buy	11,300 +4,600	+69%	+$60.8K	0.02%	724
2016 Q3	$78K	Sell	6,700 -2,800	-29%	-$32.9K	0.01%	884
2016 Q2	$103K	Buy	+9,500	New	+$98K	0.01%	867

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

NumerixS Investment Technologies's MNTA Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 600 shares — an estimated $20K sold.

NumerixS Investment Technologies first reported a position in MNTA in Q2 2016 and held it in 10 quarters. The position peaked at $232K in Q1 2017. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

NumerixS Investment Technologies reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
NumerixS Investment Technologies sold 600 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $20K.
NumerixS Investment Technologies first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2016 and held it in 10 quarters.
NumerixS Investment Technologies's Momenta Pharmaceuticals, Inc. position peaked at $232K in Q1 2017.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.